HomeDC4 • ETR
add
DexCom Inc
Previous close
€71.18
Day range
€71.47 - €72.31
Year range
€51.62 - €121.80
Market cap
31.47B USD
Avg Volume
376.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.04B | 12.49% |
Operating expense | 455.30M | -1.19% |
Net income | 105.40M | -28.01% |
Net profit margin | 10.17 | -36.04% |
Earnings per share | 0.32 | 0.00% |
EBITDA | 193.70M | 26.11% |
Effective tax rate | 31.69% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.70B | -6.75% |
Total assets | 6.75B | 4.16% |
Total liabilities | 4.49B | 5.90% |
Total equity | 2.27B | — |
Shares outstanding | 392.11M | — |
Price to book | 12.31 | — |
Return on assets | 5.05% | — |
Return on capital | 7.00% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 105.40M | -28.01% |
Cash from operations | 183.80M | -12.14% |
Cash from investing | 100.20M | 33.96% |
Cash from financing | 12.50M | 165.96% |
Net change in cash | 298.80M | 4.88% |
Free cash flow | 67.92M | -39.14% |
About
DexCom, Inc. is an American healthcare company that develops, manufactures, produces, and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California; and has manufacturing facilities in Mesa, Arizona; Batu Kawan, Malaysia; and Athenry, Ireland. Wikipedia
Founded
1999
Headquarters
Website
Employees
10,250
